Our Pipeline

At NeuDirection, we are dedicated to developing a robust and diverse pipeline of innovative neurological therapies. Our pipeline encompasses a range of promising small molecules and neuropeptide-based drug candidates, each targeting specific G protein-coupled receptors (GPCRs) in the brain. By exploring novel mechanisms and pathways, we aim to address significant unmet medical needs in the treatment of neurological disorders.

See more on our pipeline

Our current focus is on three groundbreaking drug candidates:

Amblyopia

Tinnitus

Epilepsy